CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33 | -99.9% | 5,789 | -7.6% | 0.00% | – |
| Q3 2022 | $41,000 | – | 6,262 | +4248.6% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 144 | -98.3% | 0.00% | – |
| Q1 2022 | $28,000 | -60.0% | 8,468 | -51.0% | 0.00% | – |
| Q3 2021 | $70,000 | -2.8% | 17,288 | 0.0% | 0.00% | – |
| Q2 2021 | $72,000 | +30.9% | 17,288 | +55.6% | 0.00% | – |
| Q1 2021 | $55,000 | +358.3% | 11,112 | +810.8% | 0.00% | – |
| Q2 2020 | $12,000 | -29.4% | 1,220 | -37.5% | 0.00% | – |
| Q1 2020 | $17,000 | -87.3% | 1,951 | -86.6% | 0.00% | – |
| Q4 2019 | $134,000 | +252.6% | 14,605 | +122.7% | 0.00% | – |
| Q3 2019 | $38,000 | +171.4% | 6,557 | +442.8% | 0.00% | – |
| Q2 2019 | $14,000 | – | 1,208 | +5652.4% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 21 | -79.2% | 0.00% | – |
| Q3 2018 | $1,000 | -98.5% | 101 | -97.4% | 0.00% | – |
| Q2 2018 | $65,000 | – | 3,865 | +21372.2% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 18 | -99.9% | 0.00% | -100.0% |
| Q3 2017 | $222,000 | +241.5% | 15,058 | +221.8% | 0.01% | +200.0% |
| Q2 2017 | $65,000 | +170.8% | 4,680 | +219.9% | 0.00% | +200.0% |
| Q1 2017 | $24,000 | -48.9% | 1,463 | -41.1% | 0.00% | -75.0% |
| Q4 2015 | $47,000 | – | 2,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |